Form D · Biotechnology

Breathe Technologies, Inc.

Irvine, CA · CIK 0001701956

Offering snapshot reported Nov 2, 2017 · SEC filing

Reported sold
$6.25M
Offering amount: $25M
Investors reported
10
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Oct 25, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 2, 2017Initial$6,250,001No comparison10SEC filing
Sep 27, 2017Amendment$8,500,000$4,250,000vs Mar 27, 201713SEC filing
Mar 27, 2017Initial$4,250,000No comparison13SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-297999
Series B

Source: Form D, filed Nov 2, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Samir Ahmad Executive
Gary Berman Executive
Steven Hochberg Director
Steve Hochberg Director
Ted Huber Director
Lawrence Mastrovich Director, Executive
Neil Meyer Director
John Miclot Director
Beth Seidenberg Director
John Spilman Director
Bruce Steel Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
175 Technology Dr., Ste. 100
Irvine, CA, 92618